** = Publications listed in SCI/SSCI/Pubmed
** Abooali, M; Lei, X; Yasinska, IM; Schlichtner, S; Hussain, R; Siligardi, G; Gianga, TM; Berger, SM; Cholewa, D; Gibbs, BF; Fasler-Kan, E; Sumbayev, VV
Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cells.
Immunooncol Technol. 2025; 28:101533
Doi: 10.1016/j.iotech.2025.101533
[OPEN ACCESS]
PubMed
FullText
FullText_MUG